The Changes and Effects of the Plasma Levels of Tumor Necrosis Factor after Coronary Artery Bypass Surgery with Cardiopulmonary Bypass
- 1 August 2006
- journal article
- research article
- Published by Forum Multimedia Publishing LLC in The Heart Surgery Forum
- Vol. 9 (4) , E703-E709
- https://doi.org/10.1532/hsf98.20061012
Abstract
Metapress is the fastest-growing resource of expert content online -- Discover more about what interests you, learn new skills, and find inspiration.Keywords
This publication has 48 references indexed in Scilit:
- Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery?The Annals of Thoracic Surgery, 2000
- Differing Effects of Aprotinin and ϵ-Aminocaproic Acid on Cytokine-Induced Inducible Nitric Oxide Synthase ExpressionThe Annals of Thoracic Surgery, 1997
- Preventing the inflammatory response to open-heart surgery: The role of aprotinin and other protease inhibitorsInternational Journal of Cardiology, 1996
- Pretreatment of Human Myocardium with Adenosine During Open Heart SurgeryJournal of Cardiac Surgery, 1995
- Nitric Oxide Accounts for Postischemic Cardioprotection Resulting from Angiotensin-Converting Enzyme InhibitionJournal of Cardiovascular Pharmacology, 1995
- Biocompatibility of Heparin‐Coated Membrane Oxygenator During Cardiopulmonary BypassArtificial Organs, 1994
- Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1992
- Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenationThe Annals of Thoracic Surgery, 1992
- Tumor necrosis factor in the pathophysiology of infection and sepsisClinical Immunology and Immunopathology, 1990
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981